2008
DOI: 10.1080/14653240802061146
|View full text |Cite
|
Sign up to set email alerts
|

Beneficial effects of fetal–maternal microchimerism on the activated haplo-identical peripheral blood stem cell treatment for cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
0
2

Year Published

2008
2008
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 30 publications
1
10
0
2
Order By: Relevance
“…and some non-immune cells (such as vascular endothelial cells, epidermal cells, fibroblasts, etc.). As a kind of molecule for cell signal transduction, cytokines mainly regulate immune response, participate in immune cell differentiation and development, mediate inflammatory response and stimulate the hematopoietic function and tissue repair [26].…”
Section: Discussionmentioning
confidence: 99%
“…and some non-immune cells (such as vascular endothelial cells, epidermal cells, fibroblasts, etc.). As a kind of molecule for cell signal transduction, cytokines mainly regulate immune response, participate in immune cell differentiation and development, mediate inflammatory response and stimulate the hematopoietic function and tissue repair [26].…”
Section: Discussionmentioning
confidence: 99%
“…Using HLA markers, the fetal or maternal (maternal cells in children) microchimerism status (+ or -) of patients was determined prior to treatment with the haplo-PBSC derived from the donor. Both the survival time and therapeutic response rate of microchimerism-positive patients was higher than in microchimerism-negative patients (8). In yet another study, the percentage of parous patients with malignancies that were positive for fetal microchimeric cells was significantly less than for normal parous donors (9).…”
Section: Fetal Microchimeric Cells Suppress Cancermentioning
confidence: 81%
“…La probabilité d'avoir un cancer serait moindre chez les femmes multipares avec microchimé risme que chez celles sans microchimé risme [92]. Le MCF serait moins fré quent dans le sang pé riphé rique de femmes pré sentant certains types de cancer [14,93,94].…”
Section: Microchime´risme Foetal Et Cancersunclassified